A UK prospective multicentre decision impact, decision conflict and economic evaluation of the 21-gene assay in women with node+ve, hormone receptor+ve, HER2-ve breast cancer. Simon Holt et al. Br J Cancer 2024

https://phgkb.cdc.gov/PHGKB/translationClip.action?action=home